2023
DOI: 10.3389/fgene.2023.1117821
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenic gene variants in CCDC39, CCDC40, RSPH1, RSPH9, HYDIN, and SPEF2 cause defects of sperm flagella composition and male infertility

Abstract: Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder affecting the function of motile cilia in several organ systems. In PCD, male infertility is caused by defective sperm flagella composition or deficient motile cilia function in the efferent ducts of the male reproductive system. Different PCD-associated genes encoding axonemal components involved in the regulation of ciliary and flagellar beating are also reported to cause infertility due to multiple morphological abnormalities of the sperm flagella … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 49 publications
1
5
0
Order By: Relevance
“…Taken altogether, DNAI1 and DNAH5 abnormalities account for about 30% of PCD cases; however, mutations in the other thirty genes might lead to various ciliary ultrastructural defects and might explain 70% of the genetic causes of PCD [118]. As known and well-evident from our data collection, MMAF pathogenic genes are also often reported to result in PCD or PCD-like symptoms [71,111]. Those genes include genes encoding the axonemal ruler proteins CCDC39 and CCDC30 or genes encoding the proteins SPEF2 [111].…”
Section: Pcdsupporting
confidence: 52%
See 1 more Smart Citation
“…Taken altogether, DNAI1 and DNAH5 abnormalities account for about 30% of PCD cases; however, mutations in the other thirty genes might lead to various ciliary ultrastructural defects and might explain 70% of the genetic causes of PCD [118]. As known and well-evident from our data collection, MMAF pathogenic genes are also often reported to result in PCD or PCD-like symptoms [71,111]. Those genes include genes encoding the axonemal ruler proteins CCDC39 and CCDC30 or genes encoding the proteins SPEF2 [111].…”
Section: Pcdsupporting
confidence: 52%
“…As known and well-evident from our data collection, MMAF pathogenic genes are also often reported to result in PCD or PCD-like symptoms [71,111]. Those genes include genes encoding the axonemal ruler proteins CCDC39 and CCDC30 or genes encoding the proteins SPEF2 [111]. Therefore, dividing genes causing only MMAF and genes causing PCD is not always easy and immediate, and it is possible to define MMAF and PCD as a "phenotypic continuum" [113].…”
Section: Pcdmentioning
confidence: 70%
“…The genes involved in downregulation were identified as CFAP70 , TTC29 , CCDC40 , DNAAF4 , SYCE3 , STK36 , SPI1 , and EMX2 . These genes were found to be enriched in various pathways related to sex development, sperm growth, and sperm motility, such as organelle assembly, cilia movement, the development of the urogenital system, sperm production, and sperm deformity [ 47 , 48 ]. Significantly, various studies have shown that these genes contribute to reproductive development.…”
Section: Discussionmentioning
confidence: 99%
“…Genetic diagnoses were established using regular gene testing including Sanger sequencing of PCD genes. In most cases, targeted PCD gene panels were used as previously described ( Raidt et al, 2022 ; Aprea et al, 2023 ). In a few cases, whole-exome sequencing was performed, and data were analyzed only for DNA variants in previously published PCD genes.…”
Section: Methodsmentioning
confidence: 99%
“…All DNA variants were evaluated according to the guidelines of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) ( Richards et al, 2015 ), and only pathogenic (class 5)/likely pathogenic variants (class 4) were included. The pathogenicity of genetic variants was determined as previously described using in silico calculation programs (e.g., Varsome) ( Raidt et al, 2022 ; Aprea et al, 2023 ). Gene nomenclature was used according to the current approved HGNC [human genome organization (HUGO); ( https://www.genenames.org/ )] ( Bruford et al, 2020 ).…”
Section: Methodsmentioning
confidence: 99%